Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 2/20 | 0.53 |
| ▸ | TBXAS1 | P24557 | 7/20 | 0.51 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | FDPS | P14324 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | HRH1 | P35367 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL770135 | 0.88 | TBXAS1 (0.59) | CHRNA7TBXAS1NAPRTCYP2A6FDPS | |
| SCHEMBL27273694 | 0.84 | CHRM2 (0.50) | CHRNA7TBXAS1 | |
| SCHEMBL15758434 | 0.81 | CHRNA7 (0.53) | CHRNA7TBXAS1NAPRTCYP2A6TDP1 | |
| SCHEMBL4245616 | 0.81 | CHRNA7 (0.58) | CHRNA7TBXAS1CYP2A6TDP1L3MBTL1 | |
| SCHEMBL1272886 | 0.81 | CHRNA7 (0.53) | CHRNA7TBXAS1NAPRTCYP2A6TDP1 | |
| SCHEMBL1272883 | 0.81 | CHRNA7 (0.53) | CHRNA7TBXAS1NAPRTCYP2A6TDP1 | |
| SCHEMBL496895 | 0.81 | NAPRT (0.53) | CHRNA7TBXAS1NAPRTFDPS | |
| SCHEMBL23795746 | 0.80 | TDP1 (0.65) | TBXAS1CYP2A6TDP1L3MBTL1HRH1 | |
| Sulfuric Acid SCHEMBL28849514 | 0.80 | TDP1 (0.61) | CHRNA7TBXAS1NAPRTCYP2A6FDPS | |
| SCHEMBL23795734 | 0.79 | TDP1 (0.59) | TBXAS1CYP2A6TDP1L3MBTL1HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113390983-B | Detection method for simultaneously determining 3 impurities in Voranolan fumarate | 株洲千金药业股份有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-113390983-A | Detection method for simultaneously determining 3 impurities in Voranolan fumarate | 株洲千金药业股份有限公司 | 2021-09-14 | — | — | CN | claimed |
| WO-2023189803-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION | 日産化学株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023189799-A1 | SELF CROSS-LINKABLE POLYMER AND RESIST UNDERLAYER FILM-FORMING COMPOSITION | 日産化学株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-11724997-B2 | Compounds and compositions for treating conditions associated with APJ receptor activity | ANNAPURNA BIO, INC. (US) | 2023-08-15 | — | — | US | disclosed |
| US-11724997-B2 | Compounds and compositions for treating conditions associated with APJ receptor activity | ANNAPURNA BIO, INC. (US) | 2023-08-15 | — | — | US | disclosed |
| US-11724997-B2 | Compounds and compositions for treating conditions associated with APJ receptor activity | ANNAPURNA BIO, INC. (US) | 2023-08-15 | — | — | US | disclosed |
| CN-113390983-B | Detection method for simultaneously determining 3 impurities in Voranolan fumarate | 株洲千金药业股份有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-113390983-B | Detection method for simultaneously determining 3 impurities in Voranolan fumarate | 株洲千金药业股份有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-113390983-A | Detection method for simultaneously determining 3 impurities in Voranolan fumarate | 株洲千金药业股份有限公司 | 2021-09-14 | — | — | CN | disclosed |
| CN-113390983-A | Detection method for simultaneously determining 3 impurities in Voranolan fumarate | 株洲千金药业股份有限公司 | 2021-09-14 | — | — | CN | disclosed |
| US-20100121054-A1 | PROCESS FOR PRODUCING SUBSTITUTED METHYLAMINE COMPOUND AND TRIAZINE DERIVATIVE | NIPPON SODA CO., LTD. (JP) | 2010-05-13 | — | — | US | disclosed |
| EP-2141149-A1 | PROCESS FOR PRODUCING SUBSTITUTED METHYLAMINE COMPOUND AND TRIAZINE DERIVATIVE | Nippon Soda Co., Ltd. (JP) | 2010-01-06 | — | — | EP | disclosed |
| CN-1042899-C | Catalyst compositions and Catalytic processes | PHILLIPS PETROLEUM CO (US) | 1999-04-14 | — | — | CN | disclosed |
| EP-0603557-B1 | Catalyst compositions and catalytic processes | PHILLIPS PETROLEUM CO (US) | 1997-07-30 | — | — | EP | disclosed |
| US-5461126-A | Process of polymerizing olefins using organonickel catalyst compositions | PHILLIPS PETROLEUM COMPANY (US) | 1995-10-24 | — | — | US | disclosed |
| CN-1091999-A | Carbon monoxide-olefin polymeric and Catalytic processes | PHILLIPS PETROLEUM CO (US) | 1994-09-14 | — | — | CN | disclosed |
| US-5332708-A | Ethylene polymerization catalyst, organonickel compound and a heterocyclic nitrogen compound | PHILLIPS PETROLEUM COMPANY (US) | 1994-07-26 | — | — | US | disclosed |
| EP-0603557-A1 | Catalyst compositions and catalytic processes | PHILLIPS PETROLEUM COMPANY (US) | 1994-06-29 | — | — | EP | disclosed |
| US-4198504-A | ANTIBIOTIC | BRISTOL-MYERS COMPANY (US) | 1980-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11724997-B2 | Compounds and compositions for treating conditions associated with APJ receptor activity | APLNR, AGTR1, AGTR2 | CHRNA7 2512/4885TBXAS1 1329/4885NAPRT 1949/4885 |
| US-20100121054-A1 | PROCESS FOR PRODUCING SUBSTITUTED METHYLAMINE COMPOUND AND TRIAZINE DERIVATIVE | INMT, BHMT2, HNMT | CHRNA7 388/4885TBXAS1 2208/4885NAPRT 2215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.